November 26, 2021
SOLZY - 250/500 is an Azithromycin tablet available in 250 mg and 500 mg strengths. It is formulated to support the treatment of various bacterial infections under medical supervision. Manufactured by Kentapil Pharma, it is produced following high-quality pharmaceutical manufacturing standards.
SOLZY - 250/500 from Kentapil Pharma contains Azithromycin in 250 mg and 500 mg tablet strengths. It is prescribed by healthcare professionals for the treatment of susceptible bacterial infections involving the respiratory tract, skin, soft tissues, ears, and certain other bacterial conditions. The tablets are manufactured in quality-controlled facilities using stringent pharmaceutical standards to ensure consistency, safety, and reliability. SOLZY - 250/500 offers convenient dosing as directed by a physician and should be used only after proper medical evaluation. Patients should complete the prescribed treatment course and follow healthcare guidance to promote responsible antibiotic use and effective infection management.
Solzy-100 / 200 Azithromycin Oral Suspension by Kentapil Pharma is an azithromycin-based antibiotic oral suspension formulated for pediatric use. It is designed for convenient dosing, reliable quality, pleasant taste, and effective support in treating susceptible bacterial infections under medical supervision.
Solzy-100 / 200 Azithromycin Oral Suspension from Kentapil Pharma is a high-quality azithromycin antibiotic formulation developed to provide reliable treatment for susceptible bacterial infections in children, as prescribed by healthcare professionals. Manufactured under stringent quality standards, the suspension offers accurate dosing, excellent stability, and a pleasant taste to improve patient compliance. The product is carefully formulated for consistent therapeutic performance and easy administration. Kentapil Pharma is committed to delivering safe, effective, and quality pharmaceutical products that meet healthcare needs while ensuring trusted manufacturing practices, dependable packaging, and customer satisfaction across domestic and international markets.
CV-CIN-625 Amoxycillin 500 mg + Clavulanate Acid 125 mg Tablets by Kentapil Pharma combines amoxycillin and clavulanate acid in a trusted formulation, manufactured under stringent quality standards to support the treatment of susceptible bacterial infections when prescribed by qualified healthcare professionals.
CV-CIN-625 Amoxycillin 500 mg + Clavulanate Acid 125 mg Tablets from Kentapil Pharma is a premium-quality antibiotic formulation designed to help manage susceptible bacterial infections under the guidance of healthcare professionals. Combining amoxycillin with clavulanate acid, the formulation is manufactured in GMP-compliant facilities using strict quality control measures to ensure safety, consistency, and reliability. The tablets are carefully packaged to maintain product integrity and support convenient distribution. Kentapil Pharma remains committed to delivering dependable pharmaceutical products that meet high industry standards while focusing on quality manufacturing, customer satisfaction, and trusted healthcare solutions for domestic and international markets.
CV-CIN Amoxycillin 200 mg + Clavulanate Acid 28.5 mg Dry Syrup by Kentapil Pharma is a quality antibiotic formulation manufactured under stringent standards, offering reliable composition, convenient reconstitution, and dependable performance for the treatment of susceptible bacterial infections when prescribed by healthcare professionals.
CV-CIN Amoxycillin 200 mg + Clavulanate Acid 28.5 mg Dry Syrup from Kentapil Pharma is a premium-quality antibiotic formulation developed to support the treatment of susceptible bacterial infections under the guidance of healthcare professionals. The combination of amoxycillin and clavulanate acid is manufactured in GMP-compliant facilities using advanced production processes and rigorous quality control standards. Designed for easy reconstitution and accurate dosing, the dry syrup provides convenience for pediatric administration. Kentapil Pharma is dedicated to delivering safe, reliable, and high-quality pharmaceutical products with consistent performance, secure packaging, and a strong commitment to customer satisfaction in domestic and international healthcare markets.
GEFEX-100/200 Cefixime 100/200 mg + LBS 2.5 Billion Spores Tablets by Kentapil Pharma is a quality pharmaceutical formulation combining cefixime with lactic acid bacillus spores, manufactured under stringent standards for reliable performance when prescribed by qualified healthcare professionals.
GEFEX-100/200 Cefixime 100/200 mg + LBS 2.5 Billion Spores Tablets from Kentapil Pharma is a premium-quality formulation designed to deliver dependable pharmaceutical quality under the guidance of healthcare professionals. Combining cefixime with lactic acid bacillus (LBS) spores, the product is manufactured in GMP-compliant facilities using advanced production processes and strict quality control measures. The formulation is carefully packaged to maintain product stability and consistency throughout its shelf life. Kentapil Pharma is committed to providing safe, reliable, and high-quality pharmaceutical solutions that meet industry standards while ensuring customer satisfaction and trusted healthcare support across domestic and international markets.
GEFEX-0 by Kentapil Pharma combines Cefixime 200 mg and Ofloxacin 200 mg to help manage a broad range of bacterial infections. Formulated for reliable antimicrobial action, it is manufactured under strict quality standards to support consistent pharmaceutical performance.
GEFEX-0 from Kentapil Pharma is a combination antibiotic tablet containing Cefixime 200 mg and Ofloxacin 200 mg. This formulation is developed to provide broad-spectrum antibacterial coverage against susceptible bacterial infections. Manufactured in compliance with stringent quality standards, GEFEX-0 ensures consistent formulation, purity, and reliability. The product is intended for prescription use under the guidance of a qualified healthcare professional. Kentapil Pharma focuses on delivering high-quality pharmaceutical products through advanced manufacturing practices and quality assurance processes. GEFEX-0 is supplied with secure packaging to maintain product integrity and support dependable pharmaceutical distribution.
GEFEX Cefixime 50 mg Dry Syrup by Kentapil Pharma is a prescription antibiotic formulation developed for pediatric use. Manufactured under stringent quality standards, it offers consistent quality, reliable formulation, and convenient reconstitution for accurate dosing as directed by a healthcare professional.
GEFEX Cefixime 50 mg Dry Syrup from Kentapil Pharma is a high-quality antibiotic formulation designed for pediatric patients. Manufactured in a GMP-compliant facility, the product undergoes rigorous quality checks to ensure purity, consistency, and safety. The dry syrup is easy to reconstitute with water, allowing convenient administration and accurate dosing as prescribed by a healthcare professional. Secure packaging helps maintain product stability during storage and transportation. Kentapil Pharma is committed to delivering reliable pharmaceutical products that meet industry standards. GEFEX Dry Syrup should be used only on the advice of a qualified healthcare professional.
DOX-200 by Kentapil Pharma contains Cefpodoxime Proxetil 200 mg in a prescription tablet formulation. Manufactured under stringent quality standards, it offers consistent pharmaceutical quality, reliable performance, and secure packaging to maintain product integrity throughout storage and distribution.
DOX-200 by Kentapil Pharma is a prescription antibiotic tablet containing Cefpodoxime Proxetil 200 mg. The formulation is manufactured in a GMP-compliant facility using advanced production processes to ensure consistency, purity, and quality. Every batch undergoes rigorous quality control to meet pharmaceutical industry standards. Secure blister packaging helps preserve product stability during storage and transportation. Kentapil Pharma is dedicated to delivering reliable pharmaceutical formulations backed by strict quality assurance practices. DOX-200 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should always follow the prescribing physician's recommendations.
DOXIM 250/500 by Kentapil Pharma contains Cefuroxime Axetil in 250 mg and 500 mg tablet strengths. Manufactured under stringent quality standards, it delivers consistent pharmaceutical quality, reliable formulation, and secure packaging for dependable prescription use.
DOXIM 250/500 from Kentapil Pharma is a prescription antibiotic tablet containing Cefuroxime Axetil, available in 250 mg and 500 mg strengths. Manufactured in a GMP-compliant facility, the formulation is developed using advanced pharmaceutical processes to ensure consistent quality, purity, and reliability. Every batch undergoes stringent quality control to meet industry standards before distribution. The tablets are packed in protective blister packaging to preserve product stability and integrity during storage and transportation. Intended for use under the supervision of a qualified healthcare professional, DOXIM 250/500 reflects Kentapil Pharma’s commitment to delivering trusted, high-quality pharmaceutical formulations.
DOX-CV by Kentapil Pharma combines Cefpodoxime Proxetil 200 mg with Clavulanate Potassium 125 mg in a quality-assured tablet formulation. Manufactured to stringent pharmaceutical standards, it provides reliable quality, consistent performance, and convenient dosing for healthcare professionals and pharmaceutical distribution.
DOX-CV Cefpodoxime Proxetil 200 mg + Clavulanate Potassium 125 mg Tablets from Kentapil Pharma are formulated to deliver dependable pharmaceutical quality and consistency. This combination antibiotic is manufactured under strict GMP-compliant processes to ensure purity, safety, and effectiveness. The addition of Clavulanate Potassium enhances the antibacterial activity of Cefpodoxime by helping overcome certain bacterial resistance mechanisms. Available in a convenient oral tablet form, DOX-CV is intended for use under the guidance of qualified healthcare professionals for susceptible bacterial infections. Kentapil Pharma remains committed to providing trusted, high-quality pharmaceutical products that support modern healthcare needs and patient well-being.
DOX-50 by Kentapil Pharma contains Cefpodoxime Proxetil 50 mg and Clavulanate 31.25 mg in a quality-assured dry syrup formulation. Manufactured under stringent pharmaceutical standards, it ensures consistent quality, reliable performance, and convenient administration under healthcare professional guidance.
DOX-50 Cefpodoxime Proxetil 50 mg + Clavulanate 31.25 mg Dry Syrup from Kentapil Pharma is manufactured to meet stringent pharmaceutical quality standards. This combination formulation contains Cefpodoxime Proxetil, a broad-spectrum cephalosporin antibiotic, and Clavulanate, which helps enhance antibacterial effectiveness against certain resistant bacteria. The dry syrup dosage form offers convenient preparation and administration, particularly for pediatric patients, when prescribed by a qualified healthcare professional. Produced in GMP-compliant facilities, DOX-50 delivers consistent quality, purity, and safety. Kentapil Pharma remains committed to providing dependable pharmaceutical products that support quality healthcare through reliable manufacturing practices and trusted formulations.
SOLO-200/400 by Kentapil Pharma contains Ofloxacin 200 mg and 400 mg, a broad-spectrum antibiotic used to manage various bacterial infections. Manufactured under stringent quality standards, it offers reliable effectiveness, consistent quality, and convenient dosing for healthcare professionals and pharmaceutical distribution.
SOLO-200/400 Ofloxacin 200 mg / 400 mg Tablets from Kentapil Pharma are formulated with high-quality Ofloxacin, a broad-spectrum fluoroquinolone antibiotic. These tablets are manufactured in compliance with stringent pharmaceutical quality standards to ensure consistency, purity, and reliability. They are intended for use by qualified healthcare professionals in the management of susceptible bacterial infections, based on appropriate clinical judgment. Available in both 200 mg and 400 mg strengths, SOLO-200/400 provides flexible dosing options to meet diverse therapeutic requirements. Kentapil Pharma is committed to delivering dependable pharmaceutical products that prioritize quality, safety, and patient care while supporting healthcare providers with trusted formulations.
SOLO-OZ by Kentapil Pharma combines Ofloxacin 200 mg and Ornidazole 500 mg in a quality-assured tablet formulation. Manufactured under stringent pharmaceutical standards, it offers consistent quality, reliable performance, and convenient oral dosing for healthcare professionals and pharmaceutical distribution.
SOLO-OZ Ofloxacin 200 mg + Ornidazole 500 mg Tablets from Kentapil Pharma are formulated to meet high pharmaceutical quality standards. This combination brings together Ofloxacin, a broad-spectrum antibacterial agent, and Ornidazole, an antimicrobial and antiprotozoal agent, in a convenient oral tablet. Manufactured in GMP-compliant facilities, the formulation ensures consistent quality, purity, and reliability. SOLO-OZ is intended for use under the supervision of qualified healthcare professionals based on appropriate clinical evaluation. Kentapil Pharma is dedicated to delivering dependable pharmaceutical products that support modern healthcare requirements while maintaining stringent manufacturing practices, product safety, and quality assurance across every batch.
Kentapil Pharma, A Sri Ganganagar-based pharmaceutical company established in 2004, delivers trusted, high-quality medicines and healthcare products with reliable nationwide service to clients across India.
Copyright © 2026 Kentapil Pharma, All rights reserved.
This website uses cookies to provide you with the best browsing experience.